The Visage Journal

How Long Do the Effects of Muscle-Relaxing Treatments Last?

Understanding treatment duration, why results vary and what patients can realistically expect.

Written by Katy Elhammamy, Independent Prescribing PharmacistWeek of 17 August 2026

In this article

"How long will the results last?"

It is one of the most important questions to consider when discussing treatments that temporarily reduce facial muscle activity. It is also a question that does not have one universal answer.

For many patients, the visible effect of treatment is noticeable for approximately 3–4 months, although the duration can vary depending on the treatment area, individual muscle activity, treatment approach and the patient's response. Some people notice movement returning earlier, while others continue to experience a noticeable effect for longer. Understanding this variation is an important part of making an informed treatment decision.

How do muscle-relaxing treatments work?

Certain prescription medicines used in aesthetic medicine temporarily reduce communication between a nerve and the muscle it supplies. They do this by interfering with the release of acetylcholine, a neurotransmitter involved in muscle contraction.

When the treated muscle becomes less active, the repeated contraction responsible for certain dynamic facial lines is reduced. The effect is temporary.

Over time, neuromuscular function progressively returns, and muscle activity gradually increases. As this happens, movement and dynamic lines may become more noticeable again. This is why treatment does not have a fixed "expiry date" — the effect generally fades gradually rather than stopping suddenly on a particular day.

How quickly do results develop?

The effect is not usually immediate. Patients may begin to notice a reduction in muscle activity during the first few days following treatment, with the effect becoming more established over approximately 1–2 weeks.

First few days

Early changes in muscle activity may begin to develop.

Around 1–2 weeks

The treatment effect is generally more established.

Following months

The effect gradually diminishes as neuromuscular activity returns.

Approximately 3–4 months: many patients begin to notice a meaningful return of movement, although this varies considerably between individuals. It is important to remember that these are general timeframes rather than guarantees. Clinical studies have demonstrated considerable variation in the duration of effect between patients and treatment protocols.

Why doesn't the treatment last forever?

The effect is temporary because the nervous system is capable of recovering normal communication with the muscle. Following treatment, the nerve terminal is temporarily unable to release acetylcholine normally at the treated neuromuscular junction.

Over time, new functional connections develop, and neuromuscular transmission progressively recovers. As muscle activity returns, facial movement gradually becomes more noticeable. This is a normal part of the treatment's pharmacological effect and does not necessarily mean that the treatment has "failed".

Why can treatment duration vary between patients?

There are several reasons why one patient may experience a different duration of effect from another.

The treatment area

Different facial muscles have different patterns of activity. For example, muscles involved in facial expression can be activated repeatedly throughout the day. The characteristics of the individual muscle, its strength and the amount of movement required in that area can all influence the clinical response. Research has also demonstrated differences in duration between facial treatment areas. This means that a patient may notice movement returning in one area before another. That does not necessarily mean that one part of the treatment has stopped working.

Individual muscle activity

Patients naturally have different facial anatomy and muscle activity. Some people have relatively strong or highly active facial muscles, while others have less pronounced movement. The starting level of muscle activity and the degree of movement required to produce a particular facial expression can therefore influence the clinical outcome. This is one reason why treatment should be individually assessed rather than based solely on a standardised number of injection points or a fixed treatment plan.

Dose and treatment approach

The amount administered and the way treatment is planned can influence clinical response. However, more is not automatically better. The aim of an appropriately prescribed treatment is not simply to maximise muscle relaxation. It is to achieve an appropriate clinical effect while taking into account facial anatomy, muscle activity, symmetry and the individual's desired outcome. For aesthetic treatment, an overly aggressive approach can potentially result in excessive muscle weakness or an appearance that does not reflect the patient's wishes. A careful assessment is therefore more important than simply trying to make a treatment "last as long as possible".

Individual biological variation

There is considerable variation in how individuals respond to prescription treatments. Age, anatomy, muscle characteristics, previous treatment history and individual response can all contribute to differences in clinical duration. This means that two people receiving treatment in a similar area should not necessarily expect identical results. Comparing your treatment duration with a friend's experience can therefore be misleading.

Does physical exercise affect how long the effect lasts?

This is a question that comes up frequently. There is some evidence suggesting that physical activity may influence the duration of certain aesthetic treatments, but the evidence is not sufficiently consistent to say that exercise definitively causes a shorter duration of effect.

It is therefore better to regard physical activity as a possible contributing factor rather than a predictable explanation for treatment longevity. Individual variation remains much more important than trying to calculate duration from exercise levels alone.

Are some formulations longer-lasting than others?

There are several prescription botulinum toxin type A formulations used clinically, and their units are not interchangeable on a unit-for-unit basis. Studies have reported differences between formulations, including differences in onset and duration. However, comparisons are complicated by differences in dosage, treatment protocols, facial areas and the way treatment response is measured.

Some newer formulations have also been investigated with the aim of providing a longer duration of effect. However, a longer duration reported in a clinical study should not be interpreted as a guarantee that every patient will experience the same result. The appropriate treatment remains dependent on the individual patient and clinical assessment.

Can repeated treatment make it stop working?

A common concern is whether the body can become "resistant" to repeated treatment. Rarely, patients can develop neutralising antibodies against botulinum neurotoxin, which may reduce clinical effectiveness.

However, clinically significant antibody-mediated resistance appears to be uncommon. One large meta-analysis examining onabotulinumtoxinA across multiple indications found neutralising antibody formation in approximately 0.5% of evaluable patients.

This is one reason why treatment should be prescribed and administered appropriately, with unnecessary or excessively frequent treatment avoided. If a patient believes that a previously effective treatment is no longer producing the same response, this should be assessed clinically rather than assuming that the solution is simply to increase the dose.

How often should treatment be repeated?

There is no single treatment interval that is appropriate for everyone. Although many patients experience a noticeable effect for approximately 3–4 months, treatment intervals should be considered on an individual basis.

The return of some movement does not automatically mean that the entire clinical benefit has disappeared. Equally, treatment should not necessarily be repeated simply because a particular number of months has passed.

A clinician should consider:

The individual's previous response
The treatment area
The degree of returning muscle activity
The patient's treatment objectives
Previous treatment history
Whether further treatment is clinically appropriate

The purpose of follow-up is therefore not simply to determine whether treatment has "worn off". It is to assess the patient's response and decide whether any further intervention is appropriate.

What if the effect seems to have worn off early?

If you feel that the effect has not lasted as long as expected, there are several possible explanations. The treatment may have been appropriate but your individual response may simply be shorter than average.

Alternatively, the perceived change may relate to:

Increasing muscle activity
Differences between treatment areas
The degree of movement present before treatment
Individual anatomical variation
Expectations regarding the duration of treatment
A change in the appearance of static lines that are not caused solely by muscle movement

A clinical review can help determine what is actually happening rather than assuming that the treatment has failed.

Why realistic expectations matter

One of the most important parts of any aesthetic consultation is understanding that there is no guaranteed duration. A responsible clinician should be able to explain the likely range of outcomes rather than promising that a treatment will last a specific number of months.

"Most people experience a noticeable effect for around three to four months, but the duration can vary depending on the treatment area, muscle activity and your individual response."

This gives the patient a realistic expectation without creating an artificial deadline.

At Visage Aesthetics, every treatment starts with assessment

At Visage Aesthetics, we believe that good aesthetic practice begins with clinical assessment and informed consent, rather than a one-size-fits-all approach.

Before any prescription-only treatment is considered, an appropriate medical consultation is required to assess suitability, discuss relevant medical history, understand your concerns and explain the potential benefits and risks. A consultation does not automatically mean that treatment will be recommended or prescribed. The decision to prescribe and treat should always be based on an individual clinical assessment.

Our approach is centred on patient safety, appropriate treatment, natural-looking outcomes and realistic expectations.

Key takeaways

How long do the effects usually last?

For many patients, the noticeable effect lasts approximately 3–4 months, although individual results can be shorter or longer.

Does treatment wear off suddenly?

No. The effect generally fades gradually as normal neuromuscular activity returns.

Why do results vary?

Treatment area, muscle activity, dose, treatment approach and individual biological variation can all contribute to differences in duration.

Does a higher dose always last longer?

Not necessarily. Appropriate dosing should be based on clinical assessment and the desired outcome rather than simply trying to maximise duration.

Can repeated treatment cause resistance?

Clinically significant antibody-mediated resistance appears to be uncommon, although it is a recognised potential phenomenon.

When should treatment be repeated?

There is no universal schedule. The appropriate timing should be determined by the individual's response and clinical assessment.

The bottom line

The duration of a muscle-relaxing treatment is a spectrum, not a fixed expiry date. For many patients, the effect is noticeable for approximately 3–4 months, but there is considerable individual variation. The most important consideration is not simply making treatment last as long as possible. It is ensuring that any treatment is clinically appropriate, individually assessed and undertaken with realistic expectations.

At Visage Aesthetics, our priority is to provide clear, honest and evidence-informed information so that you can make an informed decision about your care.